These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Effect of community-wide conjugate pneumococcal vaccine use in infancy on nasopharyngeal carriage through 3 years of age: a cross-sectional study in a high-risk population. Millar EV; O'Brien KL; Watt JP; Bronsdon MA; Dallas J; Whitney CG; Reid R; Santosham M Clin Infect Dis; 2006 Jul; 43(1):8-15. PubMed ID: 16758412 [TBL] [Abstract][Full Text] [Related]
6. Pneumococcal vaccines: mechanism of action, impact on epidemiology and adaption of the species. Pletz MW; Maus U; Krug N; Welte T; Lode H Int J Antimicrob Agents; 2008 Sep; 32(3):199-206. PubMed ID: 18378430 [TBL] [Abstract][Full Text] [Related]
7. Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae. Dagan R Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():16-20. PubMed ID: 19366365 [TBL] [Abstract][Full Text] [Related]
14. Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005. Messina AF; Katz-Gaynor K; Barton T; Ahmad N; Ghaffar F; Rasko D; McCracken GH Pediatr Infect Dis J; 2007 Jun; 26(6):461-7. PubMed ID: 17529859 [TBL] [Abstract][Full Text] [Related]
15. Cross-sectional study of nasopharyngeal carriage of Streptococcus pneumoniae in human immunodeficiency virus-infected adults in the conjugate vaccine era. Onwubiko C; Swiatlo E; McDaniel LS J Clin Microbiol; 2008 Nov; 46(11):3621-5. PubMed ID: 18845823 [TBL] [Abstract][Full Text] [Related]
16. Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. Hicks LA; Harrison LH; Flannery B; Hadler JL; Schaffner W; Craig AS; Jackson D; Thomas A; Beall B; Lynfield R; Reingold A; Farley MM; Whitney CG J Infect Dis; 2007 Nov; 196(9):1346-54. PubMed ID: 17922399 [TBL] [Abstract][Full Text] [Related]
17. [7-valent conjugate Pneumococcal vaccine and nasopharyngeal cavity]. Piffer S Ann Ig; 2002; 14(6 Suppl 7):31-7. PubMed ID: 12638362 [TBL] [Abstract][Full Text] [Related]
18. Anticapsular serum antibody concentration and protection against pneumococcal colonization among children vaccinated with 7-valent pneumococcal conjugate vaccine. Millar EV; O'Brien KL; Bronsdon MA; Madore D; Hackell JG; Reid R; Santosham M Clin Infect Dis; 2007 May; 44(9):1173-9. PubMed ID: 17407035 [TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of heptavalent conjugate pneumococcal vaccine (Prevenar) in Germany: considering a high-risk population and herd immunity effects. Lloyd A; Patel N; Scott DA; Runge C; Claes C; Rose M Eur J Health Econ; 2008 Feb; 9(1):7-15. PubMed ID: 17333089 [TBL] [Abstract][Full Text] [Related]
20. Indirect effects of childhood pneumococcal vaccination on pneumococcal carriage among adults and older children in Australian Aboriginal communities. Mackenzie G; Carapetis J; Leach AJ; Hare K; Morris P Vaccine; 2007 Mar; 25(13):2428-33. PubMed ID: 17030493 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]